Gene therapy for the hemoglobin disorders

Seminars in Hematology

Volumn 41, Issue 4 SPEC.ISS., 2004, Pages 279-286

  Persons, Derek A ^a,c   Tisdale, John F ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Department of Hematology/Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

BETA THALASSEMIA; GENE CASSETTE; GENE THERAPY; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SICKLE CELL ANEMIA; STEM CELL GENE THERAPY;

EID: 7044220536     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.07.004     Document Type: Article

References (83)

1. J.N. Lukens The abnormal hemoglobins General principles G.F. Lee J.L.J. Foerster Wintrobe's Clinical Hemtology First ed. 1999 Williams & Wilkins Baltimore, MD 1329 1345
2. H.F. Bunn Pathogenesis and treatment of sickle cell disease N Engl J Med 337 1997 762 769
3. D.J. Weatherall The thalassemias G. Stamatoyannopoulos P. Majerus R. Perlmutter H.E. Varmus The Molecular Basis for Blood Disorders 2001 Saunders Philadelphia, PA 183 226
4. P. Pootrakul, P. Sirankapracha, S. Hemsorach A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia Blood 96 2000 2606 2612
5. S.L. Schrier Pathophysiology of thalassemia Curr Opin Hematol 9 2002 123 126
6. C.C. Hoppe, M.C. Walters Bone marrow transplantation in sickle cell anemia Curr Opin Oncol 13 2001 85 90
7. D.A. Williams, I.R. Lemischka, D.G. Nathan Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse Nature 310 1984 476 480
8. J.E. Dick, M.C. Magli, D. Huszar Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice Cell 42 1985 71 79
9. C.E. Dunbar, M. Cottler-Fox, J.A. O'Shaughnessy Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation Blood 85 1995 3048 3057
10. E.G. Hanania, R.E. Giles, J. Kavanagh Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy Proc Natl Acad Sci USA 93 1996 15346 15351
11. D. Orlic, L.J. Girard, C.T. Jordan The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction Proc Natl Acad Sci USA 93 1996 11097 11102
12. M.I. Bukrinsky, S. Haggerty, M.P. Dempsey A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells Nature 365 1993 666 669
13. J.A. Zack, A.M. Haislip, P. Krogstad Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle J Virol 66 1992 1717 1725
14. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 283 1999 682 686
15. + Mol Ther 1 2000 566 573
16. H. Hanawa, P.F. Kelly, A.C. Nathwani Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood Mol Ther 5 2002 242 251
17. D.S. An, R.P. Wersto, B.A. Agricola Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells J Virol 74 2000 1286 1295
18. D.S. An, S.K. Kung, A. Bonifacino Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques J Virol 75 2001 3547 3555
19. P.A. Horn, J.C. Morris, A.A. Bukovsky Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons Gene Ther 9 2002 1464 1471
20. S. Cowan, T. Hatziioannou, T. Cunningham Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism Proc Natl Acad Sci USA 99 2002 11914 11919
21. C. Besnier, Y. Takeuchi, G. Towers Restriction of lentivirus in monkeys Proc Natl Acad Sci USA 99 2002 11920 11925
22. H. Hanawa, P. Hematti, K. Keyvanfar, A. Krouse, R.E. Donahue, S. Kepes Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system Blood 103 2004 4062 4069
23. N.A. Kootstra, C. Munk, N. Tonnu Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells Proc Natl Acad Sci USA 100 2003 1298 1303
24. S. Karlsson, D.M. Bodine, L. Perry Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice Proc Natl Acad Sci USA 85 1988 6062 6066
25. E.A. Dzierzak, T. Papayannopoulou, R.C. Mulligan Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells Nature 331 1988 35 41
26. D. Tuan, W. Solomon, Q. Li The "beta-like-globin" gene domain in human erythroid cells Proc Natl Acad Sci USA 82 1985 6384 6388
27. D. Talbot, P. Collis, M. Antoniou A dominant control region from the human beta-globin locus conferring integration site-independent gene expression Nature 338 1989 352 355
28. F. Grosveld, G.B. van Assendelft, D.R. Greaves Position-independent, high-level expression of the human beta-globin gene in transgenic mice Cell 51 1987 975 985
29. D.A. Persons, A.W. Nienhuis Gene therapy for the hemoglobin disorders Past, present, and future Proc Natl Acad Sci USA 97 2000 5022 5024
30. M. Sadelain, C.H. Wang, M. Antoniou Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene Proc Natl Acad Sci USA 92 1995 6728 6732
31. P. Leboulch, G.M. Huang, R.K. Humphries Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure EMBO J 13 1994 3065 3076
32. H. Raftopoulos, M. Ward, P. Leboulch Long-term transfer and expression of the human beta-globin gene in a mouse transplant model Blood 90 1997 3414 3422
33. C.P. Kalberer, R. Pawliuk, S. Imren Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice Proc Natl Acad Sci USA 97 2000 5411 5415
34. S. Rivella, M. Sadelain Genetic treatment of severe hemoglobinopathies The combat against transgene variegation and transgene silencing Semin Hematol 35 1998 112 125
35. A. Grande, B. Piovani, A. Aiuti Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells Blood 93 1999 3276 3285
36. F. Moreau-Gaudry, P. Xia, G. Jiang High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors Blood 98 2001 2664 2672
37. D.E. Sabatino, N.E. Seidel, G.J. Aviles-Mendoza Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter Proc Natl Acad Sci USA 97 2000 13294 13299
38. D.W. Emery, E. Yannaki, J. Tubb Development of virus vectors for gene therapy of beta chain hemoglobinopathies Flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo Blood 100 2002 2012 2019
39. C. May, S. Rivella, J. Callegari Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin Nature 406 2000 82 86
40. R. Pawliuk, K.A. Westerman, M.E. Fabry Correction of sickle cell disease in transgenic mouse models by gene therapy Science 294 2001 2368 2371
41. D.A. Persons, P.W. Hargrove, E.R. Allay The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number Blood 101 2003 2175 2183
42. C. May, S. Rivella, A. Chadburn Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene Blood 99 2002 1902 1908
43. D.N. Levasseur, T.M. Ryan, K.M. Pawlik Correction of a mouse model of sickle cell disease lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells Blood 102 2003 4312 4319
44. S. Imren, E. Payen, K.A. Westerman Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells Proc Natl Acad Sci USA 99 2002 14380 14385
45. H.F. Bunn Induction of fetal hemoglobin in sickle cell disease Blood 93 1999 1787 1789
46. D.A. Persons, E.R. Allay, D.E. Sabatino Functional requirements for phenotypic correction of murine beta-thalassemia Implications for human gene therapy Blood 97 2001 3275 3282
47. L.S. Kean, E.A. Manci, J. Perry Chimerism and cure Hematologic and pathologic correction of murine sickle cell disease Blood 102 2003 4582 4593
48. S. Rivella, C. May, A. Chadburn A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer Blood 101 2003 2932 2939
49. J.M. Molete, H. Petrykowska, E.E. Bouhassira Sequences flanking hypersensitive sites of the beta-globin locus control region are required for synergistic enhancement Mol Cell Biol 21 2001 2969 2980
50. H. Hanawa, P.W. Hargrove, S. Kepes, A.W. Nienhuis, D.A. Persons Extended γ-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia Blood First Edition 2004 Paper, prepublished online June 15, DOI 10.1182/blood-2004-03-0863
51. B. Burgess-Beusse, C. Farrell, M. Gaszner The insulation of genes from external enhancers and silencing chromatin Proc Natl Acad Sci USA 99 suppl 4 2002 16433 16437
52. S. Rivella, J.A. Callegari, C. May The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites J Virol 74 2000 4679 4687
53. M. Cavazzana-Calvo, S. Hacein-Bey, B.G. de Saint Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
54. A. Aiuti, S. Slavin, M. Aker Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 296 2002 2410 2413
55. F.M. Stewart, R.B. Crittenden, P.A. Lowry Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice Blood 81 1993 2566 2571
56. H.S. Ramshaw, S.S. Rao, R.B. Crittenden Engraftment of bone marrow cells into normal unprepared hosts Effects of 5-fluorouracil and cell cycle status Blood 86 1995 924 929
57. S.S. Rao, S.O. Peters, R.B. Crittenden Stem cell transplantation in the normal nonmyeloablated host relationship between cell dose, schedule, and engraftment Exp Hematol 25 1997 114 121
58. M. Mardiney III, H.L. Malech Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation Implications for gene therapy Blood 87 1996 4049 4056
59. N. Giri, A. Kaushiva, T. Wu The effects of SCF/G-CSF prestimulation on radiation sensitivity and engraftment in nonmyeloablated murine hosts Exp Hematol 29 2001 779 785
60. R.D. Huhn, J.F. Tisdale, B. Agricola Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning Hum Gene Ther 10 1999 1783 1790
61. M. Rosenzweig, T.J. MacVittie, D. Harper Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning Blood 94 1999 2271 2286
62. E.M. Kang, Y. Hanazano, P. Frare Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the Fanconi anemia C gene after conditioning with low-dose irradiation Mol Ther 3 2001 911 919
63. D.A. Heim, Y. Hanazono, N. Giri Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model Mol Ther 1 2000 533 544
64. R. Shull, X. Lu, I. Dube Humoral immune response limits gene therapy in canine MPS I Blood 88 1996 377 379
65. D.A. Persons, A.W. Nienhuis In vivo selection to improve gene therapy of hematopoietic disorders Curr Opin Mol Ther 4 2002 491 498
66. S. Nesci, M. Manna, M. Andreani Mixed chimerism in thalassemic patients after bone marrow transplantation Bone Marrow Transplant 10 1992 143 146
67. F. Bernaudin, G. Souillet, J.P. Vannier Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD) The French experience GEGMO. Bone Marrow Transplant 12 suppl 1 1993 118 121
68. M. Andreani, S. Nesci, G. Lucarelli Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation Bone Marrow Transplant 25 2000 401 404
69. B.P. Sorrentino Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs Nat Rev Cancer 2 2002 431 441
70. B.M. Davis, O.N. Koc, S.L. Gerson Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection Blood 95 2000 3078 3084
71. S. Ragg, M. Xu-Welliver, J. Bailey Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells Cancer Res 60 2000 5187 5195
72. N. Sawai, S. Zhou, E.F. Vanin Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector Mol Ther 3 2001 78 87
73. L. Jin, H. Zeng, S. Chien In vivo selection using a cell-growth switch Nat Genet 26 2000 64 66
74. U. Thorsteinsdottir, G. Sauvageau, R.K. Humphries Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size Blood 94 1999 2605 2612
75. D.A. Persons, E.R. Allay, N. Sawai Successful treatment of murine {beta}-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells Blood 102 2003 506 513
76. T. Neff, P.A. Horn, V.E. Valli Pharmacologically regulated in vivo selection in a large animal Blood 100 2002 2026 2031
77. Y. Hanazono, T. Nagashima, M. Takatoku In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model Gene Ther 9 2002 1055 1064
78. T. Nagashima, Y. Ueda, Y. Hanazono In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch J Gene Med 6 2004 22 31
79. + progenitors using clinically feasible methods Mol Ther 1 2000 285 293
80. M. Takatoku, S. Sellers, B.A. Agricola Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates J Clin Invest 108 2001 447 455
81. P.A. Horn, M.S. Topp, J.C. Morris Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells Blood 100 2002 3960 3967
82. H.P. Kiem, R.G. Andrews, J. Morris Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor Blood 92 1998 1878 1886
83. L. Pauling, H.A. Itano, S.J. Singer Sickle cell anemia, a molecular disease Science 110 1949 543 548